SEC
filing details

Document Details

Form
Filing Date
Oct 24, 2023
Document Date
Oct 23, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Filer
Kassberg Thomas Richard
Sign up for Email Alerts
Email Alerts Sign-up